Table 3 FDG-PET/CT results
All patients ( n = 54) | Surgical patients ( n = 41) | Non-surgical patients ( n = 13) | |
|---|---|---|---|
No. (%) | No. (%) | No. (%) | |
Clinical report | |||
IPFU+ | 24 (44.4) | 15 (36.6) | 9 (69.2) |
Lymph node metastasis | 7 (13.0) | 3 (7.3) | 4 (30.8) |
Bone metastasis | 3 (6.0) | 0 (0.0) | 3 (23.1) |
Blinded reading* | |||
IPFU score 0 | 6 (11.1) | 6 (14.6) | 0 (0.0) |
IPFU score 1 | 18 (33.3) | 15 (36.6) | 3 (23.1) |
IPFU score 2 | 14 (25.9) | 12 (29.3) | 2 (15.3) |
IPFU score 3 | 10 (18.5) | 6 (14.6) | 4 (30.8) |
IPFU score 4 | 6 (11.1) | 2 (4.9) | 4 (30.8) |
IPFU+ (score 2 to 4) | 30 (55.6) | 20 (48.9) | 13 (76.9) |
Quantitative analysis | |||
IPFU+ (SUVmax ≥ 4.0) | 24 (44.4) | 15 (36.6) | 9 (69.2) |
Median (range) | Median (range) | Median (range) | |
Prostatic SUVmax | 3.7 (1.8 – 34.7) | 3.5 (1.8 – 24.9) | 5.9 (2.5 – 34.7) |